| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/12/2011 | US20110111016 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/12/2011 | US20110111015 Compositions and methods of enhancing immune responses to eimeria |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110110980 Heterlogous prime-boost immunization regimen |
| 05/12/2011 | US20110110978 High titer recombinant influenza viruses with enhanced replication in vero cells |
| 05/12/2011 | US20110110976 Rift valley fever virus-like particles and their use for immunization and as test system |
| 05/12/2011 | US20110110975 Inactivated virus compositions and methods of preparing such compositions |
| 05/12/2011 | US20110110974 Methods and kits for inducing a ctl response using a prime boost regimen |
| 05/12/2011 | US20110110973 Influenza B Vaccines |
| 05/12/2011 | US20110110972 Stimulation of an immune response by enantiomers of cationic lipids |
| 05/12/2011 | US20110110971 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110968 Human optimized Bacillus anthracis protective antigen |
| 05/12/2011 | US20110110966 Novel immunogenic proteins of leptospira |
| 05/12/2011 | US20110110964 Immunogenic peptides and their use in transplantation |
| 05/12/2011 | US20110110963 Gene encoding labyrinthin, a marker for cancer |
| 05/12/2011 | US20110110962 Novel Immunoadjuvant Flagellin-Based Compounds and Use Thereof |
| 05/12/2011 | US20110110953 Compound and method for treatment of chronic transplant rejection |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110931 Methods for Detecting and Monitoring Circulating Cancer Stem Cells |
| 05/12/2011 | US20110110928 Fc variants with altered binding to fcrn |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110909 Human facilitating cells |
| 05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
| 05/12/2011 | US20110110900 Novel adult progenitor cell |
| 05/12/2011 | US20110110883 Methods of altering an immune response induced by cpg oligodeoxynucleotides |
| 05/12/2011 | US20110110861 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells |
| 05/12/2011 | US20110110859 Protein |
| 05/12/2011 | DE102009053157A1 Arzneimittel enthaltend Cholin Medicines containing choline |
| 05/12/2011 | CA2816401A1 Generation of antigenic virus-like particles through protein-protein linkages |
| 05/12/2011 | CA2781322A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | CA2779839A1 T-cell stimulating protein b and methods of use |
| 05/12/2011 | CA2779574A1 Novel kinase modulators |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779384A1 Engineered anti-tslp antibody |
| 05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | CA2776563A1 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | CA2769996A1 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/11/2011 | EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319840A1 Aminopropylidene derivative |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319520A1 Immunostimulating agent |
| 05/11/2011 | EP2319502A1 Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/11/2011 | EP2319494A1 Pharmaceutical compositions for the treatment of asthma |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2318437A2 Method for treating multiple sclerosis patients with anti-il2r antibodies |
| 05/11/2011 | EP2318408A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318407A1 Pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318391A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 05/11/2011 | EP2318387A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 05/11/2011 | EP2318371A2 Novel solid state forms of laquinimod and its sodium salt |
| 05/11/2011 | EP2318045A1 Modification of allergens for immunotherapy |
| 05/11/2011 | EP2318036A2 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 05/11/2011 | EP2318023A1 Nutritional compositions containing punicalagins |
| 05/11/2011 | EP2318020A1 Immunosuppressive blood cells and methods of producing same |
| 05/11/2011 | EP2318018A2 Polysaccharides extract from dendrobium for treating allergic diseases |
| 05/11/2011 | EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis |
| 05/11/2011 | EP1803811B1 Chimeric (double) decoy |
| 05/11/2011 | EP1678209B1 Antibodies to nik, their preparation and use |
| 05/11/2011 | EP1604665B1 C-kit kinase inhibitor |
| 05/11/2011 | EP1381280B1 Viral vectors and their use in therapeutic methods |
| 05/11/2011 | EP1163262B1 Phenylalanine derivatives |
| 05/11/2011 | CN1942585B Nucleic acid construct containing full-length genome of human hepatitis c virus, method for nucleic acid construct transferring into recombinant full-length virus genome replicative cell and method of producing hepatitis C virus particle |
| 05/11/2011 | CN1692156B Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 05/11/2011 | CN1688695B New dendritic cell co stimulatory molecules |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN102057272A Novel compositions and methods for the treatment of immune related diseases |
| 05/11/2011 | CN102056927A Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 05/11/2011 | CN102056925A Compounds and compositions as kinase inhibitors |
| 05/11/2011 | CN102056622A Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 05/11/2011 | CN102051363A Clam ferroprotein gene as well as coding protein and application of in vitro recombinant expression product of same |
| 05/11/2011 | CN102051322A Jujube mixed liquor and production technology thereof |
| 05/11/2011 | CN102051321A Red jujube health-care liquor and production process thereof |
| 05/11/2011 | CN102051317A Health-care wine prepared from termite serving as main raw material |
| 05/11/2011 | CN102051275A Novel application of Artemisia rupestris L extract |
| 05/11/2011 | CN102050809A Chemokine-like factor 1 (CKLF1)/C chemokine receptor 4 (CCR4) interaction-antagonistic 3-peperazinyl coumarin derivatives |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN102050755A Novel agomelatine crystal forms and preparation methods of agomelatine crystal forms |
| 05/11/2011 | CN102049045A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 05/11/2011 | CN102048959A Dendrobium candidum compound preparation capable of regulating function of human body in two-way manner and preparation method thereof |
| 05/11/2011 | CN102048950A Nourishing and strengthening health wine and preparation method thereof |
| 05/11/2011 | CN102048921A Kang'ai body resistance-strengthening and preparation method thereof |
| 05/11/2011 | CN102048904A Preparation methods of soft-shell turtle skirt oral liquid and pills |
| 05/11/2011 | CN102048892A Formula of traditional Chinese medicine for treating allergic rhinitis |
| 05/11/2011 | CN102048850A Traditional Chinese medicine external preparation for curing infantile eczema and preparing method thereof |
| 05/11/2011 | CN102048820A Traditional Chinese medicine formula used for food sole physical therapy and physical therapy method |
| 05/11/2011 | CN102048818A Total salvianolic acid, panax notoginseng saponins, and compatibility thereof in prevention and treatment of diseases caused by microcirculatory disturbance |
| 05/11/2011 | CN102048803A Composition with fatigue resistance and immune system improving function, and preparation method and application thereof |
| 05/11/2011 | CN102048797A Preparation method and application of loofah extract |
| 05/11/2011 | CN102048795A Method for simultaneously measuring content of multiple active ingredients in common threewingnut root medicinal materials |